Introduction: Hepatitis B virus is responsible for 50%-80% of Hepatocellular carcinoma cases worldwide. In Nigeria, vertical transmission
Introduction
Hepatitis B virus is a major cause of Chronic Hepatitis, cirrhosis and Hepatocellular cancer (HCC). About 2 billion people worldwide have been infected with HBV, an estimated 360 million remain chronically infected of whom almost one million people die annually of HBVrelated liver disease [1, 2] . Of the estimated 360 million chronically infected individuals, about 50% acquired their infections either perinatally or in early childhood [2] . This is seen in sub-Saharan Africa and other HBV endemic regions, where high rates of HBeAgpositive infections in women of child-bearing age are found [2] , and is considered a major contributing factor to the high prevalence of HBV infection in these regions [3] . Despite advent of anti-viral therapies that can suppress HBV and delay progression of liver disease, most people with chronic HBV infection reside in developing countries where these drugs are neither affordable nor accessible [4] . The incidence of HBV-related HCC cases is projected to increase for at least two decades due to the high prevalence of chronic HBV infection throughout the world [4] . Regional studies in Nigeria have shown varied sero-prevalence rates, ranging from 4.7% to 15.8% [5, 6] . Till date there has been no national study on the sero-prevalence of HBV in the Nigerian population as well as the pregnant women. Most regional studies done were solely on seroprevalence of HbsAg, a few studies analyzed other serological parameters of HBV infection but no molecular study on HBV infection among pregnant women has been reported so far. In developed countries, the increased awareness, identification of mothers who are Hepatitis B surface antigen (HBsAg) and HBV DNA positive as well as adequate prophylaxis among exposed newborns was found to reduce the overall prevalence of HBV infection [7] . About 500μl of HBC wash buffer was added, sample centrifuged at 13,000 rpm for 1 minute and filtrate discarded, after which 700μl of DNA wash buffer was added and centrifuged at 13,000 rpm for 1 minute, this was done twice and the flow through discarded. About 100 μl of preheated elution buffer was added, and centrifuged at 13,000 rpm for 1 minute, this was done twice to elute the DNA. with prevalence rate in sub-Saharan Africa ranging from 9% to 12% [9, [16] [17] [18] [19] [20] [21] [22] . The presence of HBeAg indicates active viral replication in hepatocytes with high risk for developing hepatocellular carcinoma [23] . In the study, women positive for HBeAg accounted for 26.7%.
HBV DNA amplification and detection:

HBeAg transverses the placenta and induces an immune tolerance
Page number not for citation purposes 5 to the capsid viral antigen and elimination of infected hepatocytes in the infected newborn is therefore impossible without intervention [24] . All the HBsAg sero-positive pregnant women tested positive for total HBcAb hence were chronically infected and had HBV DNA identified in 86.7% of them, majority (73.33%) of whom presented in their second and third trimester. In the absence of early detection and treatment in these pregnant women, the risk of transmitting HBV to their newborns at birth is nearly 100% [24] . In our study, a high frequency of HBV infection was found among women older than 29 years. This may be due to increased risk of exposure to HBV with each pregnancy, the cumulative years of sexual exposure and risky sexual behaviour. This finding though in contrast to some other studies [6, 16] , was consistent with a similar study done in the same region [25] , all within Nigeria. Most of HBsAg-positive women were of low educational status (60%) and increasing level of education was noted to be inversely related with HBV infection, this finding was in agreement with similar studies in Nigeria [6, 10, 11, 16] , and this indicates the positive influence of education and public awareness on the carrier rate of HBV infection.
About (73.34%) of the HBsAg positive women were multi-gravida, this finding concurs with the observation that pregnant women are considered at a higher risk of HBV infection due to increased exposure to risk factors (such as blood transfusion, intravenous drugs or surgical procedures) [26] . None of the participants with previous history of blood transfusion had HBV infection, this is similar to studies done in Southern Nigeria [5, 6, 25] , and in contrast to some published studies in Northern Nigeria [10, 13, 27] . This reflects the strengthening of the national regulatory policy on universal screening of blood and blood product especially in Southern Nigeria and calls for further strengthening in the Northern part. In the index study women with multiple sexual partners were four times more likely to acquire hepatitis B virus infection than women with one sexual partner; this finding corroborates the high prevalence of HBV infection among commercial sex workers as reported in some studies [9] . It was also observed that women who had their sexual debut less than fifteen years of age were twelve times more at risk of HBV infection than those who were above fifteen years at their first sexual experience. Sexual contact with known HBV positive persons was also significantly associated with Hepatitis B virus infection among these women. Likewise, there was an increased prevalence of HBV infection among women in polygamous family setting, those whose husbands had other sexual partners and those whose husbands were unable to come home every day due to the nature of their job, thus reflecting the increased likelihood of their partners engaging in risky sexual behavior. This concurs with reports among pregnant women in Afghanistan [22] , and buttresses findings in literature ascribing sexual activity as a major risk factor for HBV infection [9, 28] . HBV Co-infection with human immunodeficiency virus (HIV) increases the rate of transmission of viral hepatitis substantially. It also increases the risk for hepatotoxicity of HAART and likelihood of onset of an AIDS-defining illness [28, 29] . The HIV/HBV co-infection rate in this study was 26.67%, this is similar to a study done in Tanzania [17] and Nigeria [29] , but quite high when compared with similar studies in Nigeria [6] , and the literature [28, 30] . This study also highlighted that some of the respondents did not fall into any of the recognized high risk groups for HBV infection as was also reported by other authors [10, 14, 18] . This is not an uncommon finding as other studies have indicated that the sensitivity of Center for Disease
Control and Prevention (CDC) risk factors for screening pregnant women for HBsAg ranges between 35 and 65% [10, 31] . This further buttress the fact that these women may have contracted the virus at birth, through household contacts or peer groups, or from unrecognized modes of transmission of HBV and this may herald even more widespread prevalence if not studied and curtailed. Our study was not without limitations. First, the results cannot be generalized to all pregnant women. As Pregnant women with prior history of HBV vaccination were not included in this study and known HBsAg positive women were also excluded from this study.
However, only a minority of eligible patients were excluded for this reason. Second, the selection of participants for the study was limited to the first 180 consenting pregnant women who met the eligibility criteria and this may have introduced a bias. However, it is unlikely that bias was introduced owing the use of a randomized sampling technique in selection of participants.
Conclusion
The result of this study brings to light the high prevalence and high 
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